CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · Science & Nature

AMB-CHMINACA

chemical compound

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionMay 28, 2025
Entity authorityQ21098942 ↗
Source-derived summary

AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.

Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.

Editorial summary

The public source identifies “AMB-CHMINACA” as chemical compound. This brief keeps that definition visible, then builds a research path around AMB-CHMINACA, chemical and compound.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current lead gives the account dated anchors—2015, 2019—that can be checked directly. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with AMB-CHMINACA, chemical and compound providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “AMB-CHMINACA”, the useful work is to connect “chemical compound” to the records capable of establishing context and consequence.

Evidence profile

Datasets, specimens, observations and peer-reviewed methods provide the appropriate test for the technical claims summarized here. The source revision retrieved here is dated May 28, 2025. The linked authority identifier is Q21098942. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2015 and 2019.

Critical limits

Scientific names, classifications and consensus can change while older terminology persists in catalogues and historical literature. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “AMB-CHMINACA”, its source revision and the description used here.
  2. Expand the search: follow AMB-CHMINACA primary sources, AMB-CHMINACA archive and AMB-CHMINACA research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “AMB-CHMINACA”?
  2. Which observation, specimen, dataset or publication supports the account?
  3. Has classification or technical consensus changed since the cited source?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “AMB-CHMINACA” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.